As of 2026-01-08, the Relative Valuation of Design Therapeutics Inc (DSGN) is (20.90) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.87 USD, the upside of Design Therapeutics Inc based on Relative Valuation is -311.7%.
The range of the Relative Valuation is (20.51) - (21.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 18.3x | 17.8x |
| Forward P/E multiples | 16.7x - 18.3x | 17.5x |
| Fair Price | (20.51) - (21.65) | (20.90) |
| Upside | -307.8% - -319.3% | -311.7% |
| Date | P/E |
| 2026-01-02 | -7.69 |
| 2025-12-31 | -7.92 |
| 2025-12-30 | -8.27 |
| 2025-12-29 | -8.27 |
| 2025-12-26 | -8.13 |
| 2025-12-24 | -8.23 |
| 2025-12-23 | -8.11 |
| 2025-12-22 | -8.41 |
| 2025-12-19 | -8.18 |
| 2025-12-18 | -7.61 |
| 2025-12-17 | -7.48 |
| 2025-12-16 | -8.12 |
| 2025-12-15 | -7.70 |
| 2025-12-12 | -7.96 |
| 2025-12-11 | -7.80 |
| 2025-12-10 | -7.96 |
| 2025-12-09 | -7.83 |
| 2025-12-08 | -8.33 |
| 2025-12-05 | -8.25 |
| 2025-12-04 | -8.29 |
| 2025-12-03 | -8.25 |
| 2025-12-02 | -7.55 |
| 2025-12-01 | -7.56 |
| 2025-11-28 | -7.93 |
| 2025-11-26 | -7.91 |
| 2025-11-25 | -7.95 |
| 2025-11-24 | -7.30 |
| 2025-11-21 | -7.05 |
| 2025-11-20 | -6.65 |
| 2025-11-19 | -6.20 |
| 2025-11-18 | -6.41 |
| 2025-11-17 | -6.27 |
| 2025-11-14 | -6.22 |
| 2025-11-13 | -5.96 |
| 2025-11-12 | -6.43 |
| 2025-11-11 | -6.55 |
| 2025-11-10 | -6.27 |
| 2025-11-07 | -6.38 |
| 2025-11-06 | -5.80 |
| 2025-11-05 | -5.53 |
| 2025-11-04 | -5.27 |
| 2025-11-03 | -5.53 |
| 2025-10-31 | -5.66 |
| 2025-10-30 | -5.51 |
| 2025-10-29 | -5.48 |
| 2025-10-28 | -5.64 |
| 2025-10-27 | -5.89 |
| 2025-10-24 | -4.84 |
| 2025-10-23 | -4.81 |
| 2025-10-22 | -4.67 |